GeneDx Corp. (WGS)
73.45
1.45 (2.01%)
At close: Jan 15, 2025, 11:09 AM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Revenue | 202.57M | 234.69M | 212.19M | 179.32M | 196.17M |
| Cost of Revenue | 141.94M | 261.44M | 228.80M | 175.30M | 113.39M |
| Gross Profit | 60.62M | -26.75M | -16.60M | 4.03M | 82.78M |
| Operating Income | -163.66M | -667.65M | -446.15M | -241.99M | -30.41M |
| Interest Income | 1.11M | 2.54M | 79.00K | 506.00K | 988.00K |
| Pretax Income | -176.69M | -598.03M | -245.39M | -241.34M | -29.70M |
| Net Income | -175.77M | -548.98M | -245.39M | -246.44M | -30.99M |
| Selling & General & Admin | 194.71M | 338.24M | 318.73M | 163.93M | 68.84M |
| Research & Development | 58.27M | 86.20M | 105.16M | 72.70M | 34.91M |
| Other Expenses | -28.69M | 6.31M | 5.66M | 9.39M | 9.45M |
| Operating Expenses | 224.28M | 430.76M | 429.55M | 246.02M | 113.20M |
| Interest Expense | n/a | 3.21M | 2.83M | 2.47M | 783.00K |
| Selling & Marketing Expenses | 60.96M | 134.91M | 112.74M | 63.18M | 39.35M |
| Cost & Expenses | 366.23M | 692.20M | 658.34M | 421.32M | 226.59M |
| Income Tax | -926.00K | -49.05M | 21.57M | 5.10M | 1.29M |
| Shares Outstanding (Basic) | 24.31M | 10.24M | 3.28M | 155.48 | 7.28M |
| Shares Outstanding (Diluted) | 24.31M | 10.24M | 3.28M | 155.48 | 7.28M |
| EPS (Basic) | -7.23 | -53.63 | -74.93 | -1.58M | -4.26 |
| EPS (Diluted) | -7.23 | -53.63 | -74.93 | -1.58M | -4.26 |
| EBITDA | -136.46M | -398.20M | -219.19M | -224.73M | -22.51M |
| Depreciation & Amortization | 33.73M | 63.03M | 23.36M | 14.13M | 6.41M |